0001209191-12-017092.txt : 20120309 0001209191-12-017092.hdr.sgml : 20120309 20120309134124 ACCESSION NUMBER: 0001209191-12-017092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120301 FILED AS OF DATE: 20120309 DATE AS OF CHANGE: 20120309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erck Stanley C CENTRAL INDEX KEY: 0001342826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 12679966 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD, #250 CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-03-01 0 0001000694 NOVAVAX INC NVAX 0001342826 Erck Stanley C C/O 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 1 1 0 0 President and CEO Options-right to buy 1.28 2012-03-01 4 A 0 900000 1.28 A 2022-03-01 Common Stock 900000 2070000 D Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant. /s/ John Herrmann, Attorney-in-fact for Stanley Erck 2012-03-09